Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford's Professor Dame Sarah Gilbert has been named a Laureate of the 5th Sunhak Peace Prize for her efforts to protect global health during the COVID-19 pandemic.

Professor Gilbert delivers a speech at the Sunhak Peace Prize ceremony © Sunhak Peace Prize

She was honoured alongside other new Laureates during a ceremony in South Korea to mark the World Summit 2022 (Summit for Peace on the Korean Peninsula).

Saïd Professor of Vaccinology Sarah Gilbert told the ceremony said: ‘It is a very great honour to be selected to receive the Sunhak Peace Prize, and to follow on from the prestigious laureates who have received the award in previous years. We can achieve so much when we work together, each bringing our different strengths.

‘The work we did to produce the Oxford AstraZeneca vaccine was exhausting and overwhelming at times, but ultimately vital and rewarding. I hope that many young people will be inspired in their career choice by knowing about what we achieved, and that governments and international organisations will work together to ensure that next time we need to respond to a disease threat, we will be better prepared than we were in 2020.’

Read the full story on the University of Oxford website

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.